Cargando…
38.2 NEURONAL AUTOANTIBODIES IN PSYCHOSIS: ENOUGH ABOUT PREVALENCE, WHAT’S THE RELEVANCE?
BACKGROUND: One source of controversy in the emerging field of autoimmune psychiatry concerns varying prevalence estimates of neuronal surface autoantibodies (NSAbs) in psychiatric disorders, particularly psychotic disorders. Differences in assay methodology and patient selection may contribute to v...
Autor principal: | Pollak, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887292/ http://dx.doi.org/10.1093/schbul/sby014.155 |
Ejemplares similares
-
38.4 PREVALENCE OF ANTI-NEURONAL ANTIBODIES IN PATIENTS ADMITTED WITH FIRST EPISODE OF PSYCHOSIS AND THEIR CLINICAL OUTCOMES
por: Scott, James, et al.
Publicado: (2018) -
Predictive tools in psychosis: what is ‘good enough’?
por: Seyedsalehi, Aida, et al.
Publicado: (2023) -
Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
por: Pollak, Thomas A., et al.
Publicado: (2018) -
MED15/382: Co-operative Interface in Medical Education on the WWW
por: Courtin, C, et al.
Publicado: (1999) -
382. Difference in Pathogens Between Hip and Knee Prosthetic Joint Infection
por: Henry, Michael, et al.
Publicado: (2019)